- Home
- CHEK vs NDRA Comparison
CHEK vs NDRA Comparison
Compare CHEK & NDRA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHEK
- NDRA
- Stock Information
- Founded
- CHEK 2004
- NDRA 2007
- Country
- CHEK Israel
- NDRA United States
- Employees
- CHEK N/A
- NDRA N/A
- Industry
- CHEK Medical Electronics
- NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
- Sector
- CHEK Health Care
- NDRA Health Care
- Exchange
- CHEK Nasdaq
- NDRA Nasdaq
- Market Cap
- CHEK 5.1M
- NDRA 5.1M
- IPO Year
- CHEK 2015
- NDRA 2017
- Fundamental
- Price
- CHEK $0.80
- NDRA $4.54
- Analyst Decision
- CHEK
- NDRA Strong Buy
- Analyst Count
- CHEK 0
- NDRA 1
- Target Price
- CHEK N/A
- NDRA $14,000.00
- AVG Volume (30 Days)
- CHEK 29.4K
- NDRA 709.8K
- Earning Date
- CHEK 11-25-2024
- NDRA 11-15-2024
- Dividend Yield
- CHEK N/A
- NDRA N/A
- EPS Growth
- CHEK N/A
- NDRA N/A
- EPS
- CHEK N/A
- NDRA N/A
- Revenue
- CHEK N/A
- NDRA N/A
- Revenue This Year
- CHEK N/A
- NDRA N/A
- Revenue Next Year
- CHEK N/A
- NDRA N/A
- P/E Ratio
- CHEK N/A
- NDRA N/A
- Revenue Growth
- CHEK N/A
- NDRA N/A
- 52 Week Low
- CHEK $0.76
- NDRA $4.41
- 52 Week High
- CHEK $3.62
- NDRA $4,882.50
- Technical
- Relative Strength Index (RSI)
- CHEK 21.50
- NDRA 31.46
- Support Level
- CHEK $0.80
- NDRA $5.23
- Resistance Level
- CHEK $1.28
- NDRA $8.80
- Average True Range (ATR)
- CHEK 0.08
- NDRA 1.58
- MACD
- CHEK -0.02
- NDRA -0.06
- Stochastic Oscillator
- CHEK 7.57
- NDRA 1.73
About CHEK Check-Cap Ltd.
Check-Cap Ltd is a clinical-stage medical diagnostics company engaged in the development of an ingestible imaging capsule that utilizes low-dose X-rays for the detection and imaging of colonic polyps and colorectal cancers, or CRC. The company is developing C-Scan, the first capsule-based system for preparation-free, colorectal cancer screening. Its scanning capsule will be swallowed and propelled by natural motility through the gastrointestinal tract and excreted naturally with no need for retrieval for data collection. The operations of the company are presently located in Israel, but it currently expects to market products in the United States, Europe, Israel and Japan.
About NDRA ENDRA Life Sciences Inc.
ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.